Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 6/20 | 0.37 |
| ▸ | SYK | P43405 | 3/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.36 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.36 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | KMO | O15229 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13299545 | 0.88 | MAPK14 (0.46) | MAPK14NOS3NOS2TGFBR1TGFBR2 | |
| SCHEMBL27687345 | 0.86 | KDM4E (0.43) | SYKNOS3NOS2MAPKAPK2CYP2A6 | |
| SCHEMBL13799174 | 0.81 | HAO2 (0.43) | MAPK14MAPKAPK2KDM4EALDH1A1POLB | |
| SCHEMBL18571278 | 0.79 | NOS3 (0.35) | NOS3NOS2MAPKAPK2 | |
| SCHEMBL3855124 | 0.78 | IDO1 (0.48) | KDM4EMEN1ALDH1A1MAPTPKM | |
| SCHEMBL2482626 | 0.76 | KDM4E (0.50) | NOS3NOS2CYP2A6KDM4EMEN1 | |
| SCHEMBL29628933 | 0.75 | ACHE (0.53) | CYP2A6MEN1ALDH1A1POLBRAB9A | |
| SCHEMBL29987004 | 0.74 | KDM4E (0.48) | NOS3NOS2CYP2A6KDM4EMEN1 | |
| Ammonia Solution, Strong SCHEMBL28695759 | 0.74 | KDM4E (0.48) | NOS3NOS2CYP2A6KDM4EMEN1 | |
| SCHEMBL13562431 | 0.73 | KMO (0.49) | SYKKMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9899612-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-20 | — | — | US | disclosed |
| US-9899612-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-20 | — | — | US | disclosed |
| WO-2016148390-A1 | A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2016-09-22 | — | — | WO | disclosed |
| WO-2015167300-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2015-11-05 | — | — | WO | disclosed |
| WO-2014185694-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2014-11-20 | — | — | WO | disclosed |
| US-20140284585-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2014-09-25 | — | — | US | disclosed |
| US-20140284585-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2014-09-25 | — | — | US | disclosed |
| US-8778508-B2 | Light-emitting organometallic complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8778508-B2 | Light-emitting organometallic complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8519130-B2 | Method for synthesis of iriduim (III) complexes with sterically demanding ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519130-B2 | Method for synthesis of iriduim (III) complexes with sterically demanding ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| WO-2009073246-A1 | METHOD FOR THE SYNTHESIS OF IRIDIUM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| WO-2009073245-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION | 2009-05-14 | — | — | US | disclosed |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION | 2009-05-14 | — | — | US | disclosed |
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2009-04-30 | — | — | US | disclosed |
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | CRY1, LAGE3, CRY2 | MAPK14 4475/4885SYK 2223/4885NOS3 3388/4885 |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | PAICS, ITPA, MPI | MAPK14 3611/4885SYK 2507/4885NOS3 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.